Search any mushroom and a medication together and you'll find a warning. Search for the case report behind it and you usually won't. Across the entire functional mushroom category, only three interactions have an actual published human case behind them — and two of those involve the same mushroom. Everything else on every warning list is reasoning from mechanism, which is worth something, but not the same thing.
Three mushroom–drug interactions are documented in published patients: maitake with warfarin (INR elevation), maitake with glibenclamide (two patients needed their diabetes dose cut or stopped), and chaga with vitamin C (additive oxalate load causing kidney injury). Every other warning — reishi and blood thinners, turkey tail and immunosuppressants, cordyceps and autoimmune drugs — is mechanistic extrapolation. That doesn't make them wrong. It means you should know which tier you're reading.
This page exists because the warnings are scattered across dozens of articles on this site and hundreds elsewhere, and almost nobody grades them. Sorting by evidence rather than by mushroom changes what you'd actually worry about.
Which Interactions Are Actually Documented?
Three, and they're worth knowing precisely.
Maitake and warfarin. A case report describes INR elevation in a patient taking a maitake extract alongside warfarin, with the authors proposing that maitake displaced warfarin from protein binding (Hanselin et al., Ann Pharmacother, 2010). One case, but the failure mode is bleeding.
Maitake and diabetes drugs. Two patients with type 2 diabetes added 500 mg of maitake daily to glibenclamide. Blood glucose fell enough that the glibenclamide was reduced in one and withdrawn in the other (Konno et al., Diabet Med, 2001). A prescription actually changed — that's about as concrete as this literature gets.
Chaga and vitamin C. A 69-year-old man taking 10 to 15 grams of chaga daily plus 500 mg of vitamin C developed acute kidney injury requiring dialysis (Kwon et al., Medicine, 2022). Ascorbate is metabolised to oxalate, and chaga is already oxalate-heavy.
Notice what that list does and doesn't contain. Two of the three involve maitake, which most buyers have never heard of. Reishi — the mushroom most frequently flagged for bleeding risk — has no published anticoagulant case report at all. Warning intensity in this category tracks how often a claim gets copied, not how well it's evidenced.
How Should You Read the Mechanistic Warnings?
As real but unquantified. A mechanistic warning says a plausible pathway exists, not that anyone has been harmed. Whether you act on it should depend on how bad the failure mode is.
| Interaction | Evidence tier | Failure mode | Reasonable response |
|---|---|---|---|
| Maitake + warfarin | Published case | Bleeding | Check INR, or don't combine |
| Maitake + sulfonylurea/insulin | Published case | Hypoglycaemia | Monitor glucose closely |
| Chaga + vitamin C | Published case | Kidney injury | Don't combine |
| Reishi + anticoagulants | Mechanistic | Bleeding | Stop before surgery |
| Any immune mushroom + immunosuppressants | Mechanistic, strong rationale | Transplant rejection | Avoid unless supervised |
| Cordyceps + autoimmune therapy | Mechanistic | Flare | Ask a specialist |
| Chaga + antidiabetic drugs | Animal data | Hypoglycaemia | Monitor when starting |
| Shiitake + anything | None documented | — | No specific action |
Which Drug Classes Deserve the Most Caution?
Immunosuppressants top the list, and the reasoning is unusually clean. Beta-glucans activate innate immunity; tacrolimus and ciclosporin suppress it. Those are opposite goals in the same body, and the failure mode after a transplant is severe. No case report exists, and none is needed to justify avoiding the combination.
Anticoagulants and antiplatelets come second. The maitake case is the only published one, but several mushrooms show antiplatelet activity in laboratory work, and bleeding is a consequence you can't take back.
Glucose-lowering drugs come third and are the easiest to manage, because you can simply measure. If you take insulin or a sulfonylurea and add maitake, chaga or cordyceps, test more often for two weeks.
Why Are There So Few Documented Cases?
Two reasons pull in opposite directions, and honesty requires both. The reassuring one is that millions of people take these products and very little has surfaced. PSK has been given to Japanese cancer patients at 3 grams a day for one to three years since 1977, alongside every drug an oncology patient takes, without an interaction literature emerging.
The uncomfortable one is that supplement adverse events are badly captured. Patients often don't tell their doctors, doctors often don't ask, and when something goes wrong the supplement is rarely the first suspect. Both chaga nephropathy cases were only identified because a kidney biopsy showed oxalate crystals and someone thought to ask what the patient was taking.
So the absence of reports is genuine evidence, just weaker evidence than it looks. Treat it as "nothing common and dramatic" rather than "nothing at all".
What About Surgery?
Stop mushroom supplements one to two weeks before any planned procedure. This is the standard precaution for supplements with any bleeding signal, and it costs you nothing given that these products work over months.
Tell the anaesthetist anyway. Surgical teams ask about supplements for exactly this reason, and "just a mushroom powder" is not a useful answer when they're deciding about bleeding risk.
Do Herbal Supplements in the Same Bottle Count?
Yes, and they're the part people forget. Mushroom blends increasingly include ashwagandha, ginseng, turmeric or black pepper extract, and several of those have interaction profiles considerably better documented than the mushrooms do.
Piperine, the black pepper compound added to boost absorption, inhibits drug-metabolising enzymes and can raise blood levels of unrelated medications. Turmeric has its own hepatotoxicity signal. If your mushroom product is a blend, read the whole ingredient list, not just the mushroom part of it.
Does the Format Change the Interaction Risk?
Probably, though nobody has studied it. A concentrated extract delivers more active compound per gram than a decoction does, and the documented cases all involved concentrated preparations or gram-scale powder intake rather than a cup of tea.
Chaga is the clearest example. Its documented interaction is oxalate-driven, and swallowing ground chaga delivers far more oxalate than drinking a decoction of it. Format is a dosing decision, as our chaga side effects guide works through.
What Should You Tell Your Doctor?
- The species, by name. "A mushroom supplement" isn't information.
- The daily dose in grams or milligrams, not the number of capsules.
- Whether it's powder, extract or tincture, and the extraction ratio if stated.
- How long you've been taking it. The documented harms are all cumulative.
- Everything else in the cabinet, especially vitamin C, fish oil and other supplements with their own interaction profiles.
Bring the bottle if you can — a photograph of the panel works too, and it beats trying to recall a Latin binomial from memory. Our label-reading guide covers what to look for so you can answer those questions accurately.
Who Should Assume the Answer Is No?
- Transplant recipients on immunosuppressant therapy
- Anyone on warfarin without INR monitoring in place
- Pregnant and breastfeeding women — see our pregnancy guide for why the answer there is different in kind
- Anyone with chronic kidney disease considering chaga
- People in active cancer treatment who haven't asked their oncologist
Frequently Asked Questions
Which mushroom has the most documented drug interactions?
Maitake, with two published human cases — INR elevation on warfarin, and glibenclamide reduction or withdrawal in two type 2 diabetes patients. That's more documented interaction than reishi, cordyceps and turkey tail have between them.
Can you take mushroom supplements with blood thinners?
Not without supervision. Only maitake has a published case, but bleeding is a consequence you can't reverse, and several species show antiplatelet activity in laboratory work. Stop one to two weeks before surgery regardless.
Do mushroom supplements interact with antidepressants?
No documented interaction exists between any functional mushroom and an SSRI or SNRI. The warnings that circulate appear to be extrapolated from unrelated herbal products, and there's no mechanism specific to mushroom beta-glucans behind them.
Is it safe to take several mushrooms together?
No interaction between mushrooms has been documented. The practical issue is dose accounting: a blend delivers a fraction of each species, so you're rarely near a trial dose of anything, and a proprietary formula may not tell you the split.
Should I stop mushroom supplements before a blood test?
Not necessary in general, but mention them if kidney function or glucose is being checked. Chaga can raise oxalate-related markers and maitake can lower glucose, and either could complicate the interpretation.
Related Articles
- Maitake Side Effects and Interactions
- Chaga Side Effects and Interactions
- Reishi Side Effects and Interactions
- Cordyceps Side Effects and Interactions
- Lion's Mane Side Effects and Interactions
- Turkey Tail Side Effects and Interactions
- Shiitake Side Effects and Interactions
- Mushroom Supplements During Pregnancy
Sources
- Hanselin MR, Vande Griend JP, Linnebur SA. INR elevation with maitake extract in combination with warfarin. Ann Pharmacother. 2010;44(1):223-224. PubMed 20040699
- Konno S, Tortorelis DG, Fullerton SA, et al. A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients. Diabet Med. 2001;18(12):1010. PubMed 11903406
- Kwon O, Kim Y, Paek JH, et al. Chaga mushroom-induced oxalate nephropathy that clinically manifested as nephrotic syndrome: a case report. Medicine (Baltimore). 2022;101(10):e28997. PMC8913114
- Memorial Sloan Kettering Cancer Center. Integrative Medicine herb monographs. mskcc.org